$3.45 +0.31 (%) Cesca Therapeutics Inc - NASDAQ

Jul. 25, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Benzinga's Top Downgrades

    Benzinga | Dec. 22, 2015 | 09:12AM EST
  2. Morning Market Gainers

    Benzinga | Dec. 2, 2015 | 09:47AM EST
  3. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 2, 2015 | 08:09AM EST
  4. US Stock Futures Edge Higher Ahead Of Beige Book, ADP Report

    Benzinga | Dec. 2, 2015 | 07:14AM EST
  5. Cesca Receives Approval for Medicare Coverage

    Benzinga | Dec. 2, 2015 | 06:00AM EST
  6. CLI Data From Cesca's Phase I/Phase II and Feasibility Studies to be Presented at the American Heart Association-Scientific Sessions Conference by Richard Powell, M.D.

    Benzinga | Nov. 9, 2015 | 06:04AM EST
  7. Miltenyi Biotec, Cesca Therapeutics' Subsidiary TotipotentRX Announce Multi-Year Commercial Agreement for Bone Marrow Transplantation

    Benzinga | Oct. 28, 2015 | 06:04AM EST
  8. St. Jude Children's Research Hospital and Cesca Therapeutics Enter Into Collaboration Agreement Targeting Bone Marrow Transplantation

    Benzinga | Oct. 1, 2015 | 06:06AM EST
  9. Cesca Therapeutics Reports Collaborative Deal with Center for Immune Cell Therapies at Memorial Sloan Kettering Cancer Center

    Benzinga | Sep. 16, 2015 | 15:01PM EST
  10. Top Performing Industries For May 26, 2015

    Benzinga | May. 26, 2015 | 10:52AM EST
  11. US Stock Futures Surge Ahead Of Manufacturing Data

    Benzinga | Jan. 2, 2015 | 07:00AM EST
  12. UPDATE: Cesca Receives Feedback From the FDA on Its Pivotal Investigational Device Exemption ("IDE") Application for Treating Critical

    Benzinga | Jan. 2, 2015 | 06:01AM EST
  13. US Stock Futures Drop Ahead Of Economic Data

    Benzinga | Nov. 20, 2014 | 07:38AM EST
  14. Cesca Therapeutics Announces Change In Executive Leadership

    Benzinga | Oct. 29, 2014 | 09:00AM EST
  15. Earnings Scheduled For September 25, 2014

    Benzinga | Sep. 25, 2014 | 06:23AM EST
  16. Morning Market Losers

    Benzinga | Jun. 13, 2014 | 09:44AM EST
  17. Morning Market Movers

    Benzinga | Jan. 22, 2014 | 10:22AM EST
  18. Morning Market Movers

    Benzinga | Jan. 21, 2014 | 10:30AM EST
  19. ThermoGenesis Announces Sale of Thermoline Product Line to Helmer Scientific

    Benzinga | Jan. 3, 2013 | 02:03AM EST
  20. THERMOGENESIS Corp. Reports Operating Results (10-Q)

    GuruFocus | Nov. 13, 2012 | 11:06AM EST
  21. Earnings Scheduled For September 20, 2012

    Benzinga | Sep. 19, 2012 | 20:03PM EST
  22. ThermoGenesis Receives $2M Cash Payment from Product Line Transaction

    Benzinga | Aug. 22, 2012 | 05:51AM EST
  23. ThermoGenesis Announces Completion of CryoSeal Product Line Transaction With Asahi

    Benzinga | Aug. 22, 2012 | 05:48AM EST
  24. Camelot Information Systems, ThermoGenesis Gapping Up Monday

    FoxBusiness | Aug. 20, 2012 | 04:30AM EST
  25. THERMOGENESIS Corp. Reports Operating Results (10-Q)

    GuruFocus | Feb. 10, 2012 | 00:49AM EST
  26. Thermogenesis Signs Worldwide Res-Q System Distribution Agreement With Arthrex for Sports Medicine Applications

    Benzinga | Jan. 10, 2012 | 05:41AM EST
  27. ThermoGenesis Announces Approval of AXP by India Ministry of Health

    Benzinga | Jan. 4, 2012 | 06:42AM EST
Trading Center